Method for uncovering deeply hidden enzyme-like behaviors from physiological time-series measures for disease detection, monitoring and other applications
11179073 · 2021-11-23
Assignee
Inventors
- Randall L. Barbour (Glen Head, NY, US)
- San-Lian S. Barbour (Glen Head, NY, US)
- Harry L. Graber (New York, NY, US)
Cpc classification
A61B5/0095
HUMAN NECESSITIES
A61B5/441
HUMAN NECESSITIES
A61B5/7246
HUMAN NECESSITIES
International classification
A61B5/145
HUMAN NECESSITIES
Abstract
A method of determining structured behavior from network adjacency matrices is described. A method of detecting physiological signals from a subject is described.
Claims
1. A method of identifying at least one biomarker in a subject, the method comprising: a) acquiring a physiological time-series measure from a set of sensors in communication with a body region of the subject while the subject is in a substantially resting state; b) converting the physiological time-series measure to a set of network adjacency matrices; and c) identifying at least one biomarker in the subject that exhibits structured co-dependent behaviors based on the set of network adjacency matrices.
2. The method of claim 1, wherein the set of sensors detects a near infrared spectroscopic signal.
3. The method of claim 1, wherein the set of sensors detects a hemoglobin-related signal in the subject, wherein the set of network adjacency matrices are based on measures of a temporal mean of the hemoglobin-related signal.
4. The method of claim 1, wherein an applied state definition is used in the converting of the physiological time-series measure to the set of network adjacency matrices.
5. The method of claim 1, wherein the structured co-dependent behaviors in the set of network adjacency matrices fit to a hyperbolic function from which a setpoint behavior can be identified.
6. The method of claim 1, wherein the time-series measure involves a measurement from a source exogeneous to the subject's body.
7. The method of claim 1, wherein the time-series measure involves a measurement from a source endogenous to the subject's body.
8. The method of claim 1, wherein the set of sensors is in contact with the subject.
9. The method of claim 1, wherein the physiological time-series measure involves a measurement from a bioelectric source.
10. The method of claim 1, wherein the physiological time-series measure is obtained from an acoustic source.
11. The method of claim 1, wherein the physiological time-series measure is obtained from a photoacoustic source.
12. The method of claim 1, further comprising performing a longitudinal measure of at least one biology-influenced signal, wherein the longitudinal measure determines changes over time in at least one of either detected signal amplitudes, network adjacency-matrix values, patterns of values within individual adjacency matrices, or co-dependencies between values in at least two adjacency matrices.
13. The method of claim 1, further comprising comparing the at least one identified biomarker in the subject to an identified biomarker obtained from a healthy subject, wherein the subject has a disease.
14. The method of claim 1, further comprising comparing the at least one identified biomarker in the subject to an identified biomarker obtained from a disease subject, wherein the subject is healthy.
15. The method of claim 1, wherein the set of sensors uses at least two sensing methods.
16. The method of claim 3, wherein the hemoglobin-related signal is oxygenated hemoglobin (oxyHb); deoxygenated hemoglobin (deoxyHb); tissue-Hb oxygen exchange (HbO2Exc), wherein Hb oxygen exchanged is defined as HbO2Exc=deoxyHb−oxyHb; total hemoglobin (Hb), wherein total Hb is defined as totalHb=deoxyHb+oxyHb; or Hb oxygen saturation, wherein Hb oxygen saturation is defined as HbO2Sat=(oxygenated Hb/total Hb)×100.
17. The method of claim 1, wherein the subject is healthy.
18. The method of claim 1, wherein the subject has a disease or cancer.
19. The method of claim 1, wherein the body region is a breast of the subject, the brain of the subject, the torso of the subject, a limb of the subject, or the skin of the subject.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4) ,
=state 5; .Math., ∇=state 6;
,
=state 7; .star-solid., ⋆=state 8;
,
=state 9; ×,+=state 10). Each combination of symbol color (Red: states 1,6; Blue: states 2,7; Green: states 3,8; Cyan: states 4,9; Magenta: States, states 5,10) and open-or-filled symbol denotes a different one of the 10 pre-transition States, as labeled in the plot. Arrow identifies an exemplary transition; from State 7 into State 6. Dotted lines identify additional Hb-component axes identified in
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
DETAILED DESCRIPTION OF THE INVENTION AND DRAWINGS
(14) Description will now be given with reference to the attached
(15) Method of Procedure for Acquiring Time-Series Measures of Hb Signal.
(16) Step 1. Target tissue(s), which can include, but are not limited to the chest, limbs, wrist, finger, head, neck, torso, shoulders, or feet, is illuminated using either contact of non-contact methods comprising at least one source, and diffusely transmitted or back-reflected light is measured using either contact or non-contact optical sensing elements comprising at least one receiver. When using arrays of discrete sources, source encoding can be accomplished using methods that vary from full time-multiplexing to full frequency encoding methods. Illumination from a given source is achieved using at least two wavelengths of light, which can include discrete or broad-area illumination techniques. Optical (photoacoustic) detection of reemitted light is achieved using receivers operated to recognize the intensity, amplitude and phase, temporal or corresponding structured-spatial properties (e.g., as is employed in spatial frequency domain imaging) of the applied illumination. When appropriate, system gain values are adjusted to the individual to ensure acquired values are within the system's operating range.
(17) For contact-based measures, applied sensors (emitters and receivers) can be stabilized with added mechanical supports, which can include use of flexible links or membranes to form an interconnected lattice that can be made to conform to nonuniform tissue boundaries. Alternatively, these can be introduced within a fabric cap or pad to conform to non-uniform tissue geometries. Also available are sensing arrays that can be housed within a low-profile pad whose driving electronics can be accomplished through a nearby wireless amplifier or by use of an electronic ribbon cable that serves to transmit power and timing signals. Also, light transmission and collection can be accomplished by use of optical fibers whose contact with the body is stabilized by suitable support structures. Also, the ease with which optical measures can be introduced into an endoscopic format indicates that tissues accessible by this class of techniques could also be examined.
(18) Step 2. Data collected in (1) is performed on subjects who are either in the seated, supine or prone position, or other body orientation(s) for which the tissue(s) under investigation are substantially stabilized. Should the data-collection protocol impose perturbations, these are employed in ways that do not overtly render target tissue measures unstable.
(19) Step 3. Data collection involves capturing a time-series of measures.
(20) Step 4. Collected wavelength data is transformed to Hb values, by applying a modified Beer-Lambert transform to yield values of ΔoxyHb and ΔdeoxyHb, which are subsequently normalized to their respective temporal mean values. If required, these measures can be further processed to yield computed values of ΔtotalHb, ΔHbO.sub.2Sat and ΔHbO.sub.2Exc. Also, if desired, acquired wavelength-dependent time-series measures can be additionally transformed to form a wavelength-dependent tomographic image by applying suitable inverse transforms, followed by subsequent conversions that equate changes in Hb concentration to the product of the wavelength-dependent extinction coefficient and computed change in the position-dependent absorption coefficient.
(21) Method of Procedure for Transforming Time-Varying Measures of Hb Signal to Yield Coefficients of Network-Dependent Features of the Hemoglobin Signal.
(22) 1. Time series of ΔdeoxyHb, ΔHbO.sub.2Exc, ΔHbO.sub.2Sat, ΔoxyHb, and ΔtotalHb, computed via the steps outlined in the preceding section, are loaded into computer memory for post-processing. Prior to loading, frequency filtering of data, or not, can be applied as desired.
2. The Hb-State corresponding to each image voxel (or source-detector channel) and time frame is computed as follows:
a. A three-dimensional temporary data-storage array is created, having the same number of rows (i.e., time frames) and columns (i.e., voxels or channels) as the data arrays loaded in Step 1, and having five layers that correspond to the five components of the Hb signal. The initial value of every array is 0.
b. Every element of the array created in Step 2.a., is assigned a value of either −1 or +1, depending on whether the value for the Hb-signal component corresponding to the layer-index value, is less than or greater than that same component's mean value at the voxel or channel location corresponding to the column index value, during the measurement time frame corresponding to the row index value. Ten distinct permutations of ‘±l’ values are logically possible and physiologically plausible. A lookup table, assigning each of these permutations to an integer in the 1-10 range, is generated.
c. A two-dimensional permanent data-storage array is created, having the same number of rows and columns as the data arrays loaded in Step 1. The initial value of every array element is 0. Every element of this array is then assigned an integer value in the range of 1 to 10, by referencing the lookup table described in Step 2.b.
3. Transition-count and transition-probability information is computed as follows:
a. A two-dimensional data-storage array is created, having ten rows and ten columns. The initial value of every array element is 0.
b. The Hb-State array in Step 2 is scanned, starting from the first row and first column; proceeding through each succeeding row of the first column until the last row is reached; then to the first row and second column; then through each succeeding row of the second column; then to the remaining columns in turn until the last row, last column is reached.
c. At the start of each transition-count operation, the Hb-State value at the current row-and-column position (by definition, row i and column j) is compared to the Hb-State value in row i+1, column j. The value of an element in the array created in Step 3.a, is increased by 1. The column coordinate of the selected array element is equal to the row i, column j Hb-State value, and the row coordinate is equal to the row i+1, column j Hb-State value.
d. After the entire array of the Hb-State values is scanned, transition probabilities are computed by applying Eq. (5) of the Preferred Embodiment to the transition-count array.
4. Pre-transition dwell-time and post-transition dwell-time information is computed as follows:
a. At the same time that the array described in Step 3.a, is created, an additional two arrays having the same dimensions and initial values of 0 in every element, are also created.
b. After the entire array of Hb-State values is scanned, as described in Step 3.b, pre-transition dwell times and post-transition dwell times are computed by applying Eq. (6) of the Preferred Embodiment to the arrays created in Step 3.a and 4.a.
5. Pre-transition mean-value and post-transition mean-value information is computed as follows:
a. At the same time that the array described in Step 3.a, is created, an additional ten arrays having the same dimensions and initial values of 0 in every element, are also created.
b. Every time the value of an element of the transition-count is incremented, as described in Step 3.c, the corresponding elements of the arrays created in Step 5.a also have their values modified. The changes in the current array-element values are computed via Eq. (8) of the Preferred Embodiment.
c. After the entire array of Hb-State values is scanned, pre-transition mean values and post-transition mean values are computed by applying Eq. (9) of the Preferred Embodiment to the arrays created in Steps 3.a and 5.a.
6. Transition-flux and transition-mass information is computed as follows:
a. At the same time that the array described in Step 3.a, is created, an additional five arrays having the same dimensions and initial values of 0 in every element, are also created.
b. Every time the value of an element of the transition-count is incremented, as described in Step 3.c, the corresponding elements of the arrays created in Step 6.a also have their values modified. The changes in the current array-element values are computed via Eq. (8) of the Preferred Embodiment.
c. After the entire array of Hb-State values is scanned, transition fluxes are computed by applying Eq. (10) of the Preferred Embodiment to the arrays created in Steps 3.a and 6.a.
d. After the entire array of Hb-State values is scanned, transition masses are computed by applying Eq. (11) of the Preferred Embodiment to the arrays created in Step 6.a.
7. After transition probabilities (Step 3), pre-transition and post-transition dwell times (Step 4), and pre-transition and post-transition mean values (Step 5) are computed, thermodynamic-parameter information is computed by applying Eq. (15) (for Boltzmann energy distributions) of the Preferred Embodiment to the arrays created in Step 3.d, Eqs. (16) and (18) (for Gibbs free energies) of the Preferred Embodiment to the arrays created in Steps 4.b and 5.c, and Eq. (19) (for network entropies) of the Preferred Embodiment to the arrays created in Steps 3.d, 4.b, 5.c and 6.c.
Effects of the Invention
(23) Having the goal of appreciating abnormal or normal tissue states under a wide range of environmental situations and subject status conditions for which prior-art uses of perturbation methods are likely to prove impractical or even harmful, and in recognition that the physiological mechanisms that sustain oxygen homeostasis in tissue can impart features that are not observable from application of feature extraction methods to the individual components of the Hb signal, the inventive methods described herein, favorably applied under a substantially resting state condition, serve to greatly expand the environments and subject status conditions wherein noninvasive Hb time-series measures of tissues can be acquired and from which a previously unrecognized dense feature space of coefficients and associated co-dependencies can be accessed.
(24) As is documented by the varied measures described in the Preferred and Alternative Embodiments, and applied to a representative tissue class (breast) and representative disease type (cancer), derived coefficients have the character of substantial independence across a wide range of coefficient types whose amplitudes appear strongly sensitive to the presence of disease. It is further recognized that the described methods, together with the opportunity to extend such methods to the other noted forms of time-varying physiological measures, support access to deeply hidden behaviors, some of which have been shown to exhibit enzyme-like behaviors. Also, having recognized that disturbances in oxygen homeostasis, as influenced by OS-induced inflammatory responses affects a wide range of disease types as well as tissue responses to differing classes of stimulation imposed by external stimuli, drugs, and interactions with tissue implants, the methods described here are deemed to significantly facilitate assessment of these behaviors and in doing so can support the following capabilities:
(25) 1. Improved detection of the level of OS-induced inflammation produced by acute viral syndromes, especially those targeting lung function. Such measures hold particular significance under situations of a pandemic wherein notable concerns of undesired disease spread can occur from affected individuals visiting key transportation hubs or other key infrastructure facilities. Being non-invasive and easily applied, the described invention is ideally suited for monitoring of subjects in low-resource-intensive environments and allows for longitudinal monitoring. Disease-sensitive biomarkers derived from the described methods should allow for more informed decisions regarding triage management, especially in situations wherein available care resources are overwhelmed.
(26) 2. Improved detection and monitoring of OS-induced inflammation produced by various forms of chronic disease (e.g., Type-II diabetes mellitus, atherosclerosis, obesity, cancer, autoimmune diseases, neurodegenerative diseases). Often these conditions pose limitations on how diagnostic workups can be performed, particularly in low-resource or remote locations. Offering noninvasive measures that can be applied to any tissue site, biomarkers derived from the network adjacency matrices and associated transforms can serve as a longitudinal monitoring tool that can alert care-givers to whether applied treatments are having the intended effects.
(27) 3. Improved monitoring of wound healing. Upregulation of signaling cascades, especially those related to inflammation are the vehicle by which tissue repair and wound healing occurs. Existing methods, which can employ the techniques of hyperspectral imaging, OCT, laser Doppler imaging, laser speckle imaging, spatial frequency domain imaging and digital camera imaging, all share the goal of producing information of individual features (e.g., individual Hb components, wound size and area, burn depth, burn scar perfusion, and collagen denaturation) and do not consider co-varying properties common to functional networks that modulate the bulk of physiological phenomena in living beings [49,50].
(28) The presence of an expected inflammatory response, reduced perfusion in affected regions and neovascularization associated with wound recovery strongly indicate that the normal oxygen homeostasis supply-demands present in healthy unaffected tissues should be strongly affected. As a consequence, we anticipate that several of the identified coefficient classes listed in the Preferred Embodiment will likely be affected. As each of these constitutes a dense array of mainly independent behaviors, the discriminatory power likely accessible from these measures as a basis for clinical guidance and characterization is significantly improved compared to existing assessment tools. Also recognized is that, because several of the listed methods can be adapted to provide time-series measures of the Hb signal, it is expected that more than one class of system capabilities (e.g., photoacoustic, holographic) are likely to benefit from the inventive matter disclosed herein.
(29) 4. Improved monitoring of the progression, or the response to therapeutic interventions, of chronic pathologies that have vascular manifestations. This class would include peripheral artery disease (PAD), and diabetic vasculopathy. The methods of the invention allow for greater ability to acquire relevant data from any tissue site with minimal disruption to subjects' activities of daily living.
(30) 5. Improved monitoring of the progression, or of the response to therapeutic interventions, of pathologies that produce skin ulcers or other dermatological lesions. This class includes the mentioned cases of PAD and diabetes, and also some cases of autoimmune diseases such as lupus and psoriasis. A related class of applications is the detection of incipient bedsores in individuals who are comatose or are conscious but bedridden.
(31) 6. The methods of the invention are potentially applicable for clinical or research environments in which the target population consists of or includes individuals who are unconscious or paralyzed. The latter category would include cases of temporary (e.g., because the subject is immobilized by a cast) as well as permanent paralysis (e.g., owing to spinal-cord injury). Also recognized is the value in distinguishing and longitudinal monitoring of variable states of consciousness resulting from injury, disease, or effects of administered drugs.
(32) 7. Recording of hemodynamic data from the brain, peripheral structures, or both, during sleep studies. These applications have the potential to yield insight into the physiological stresses induced by conditions such as sleep apnea, as well as the effectiveness of interventions such as positive airway pressure.
(33) 8. Earlier and more reliable detection of inflammatory states, in tissues lying within the limits of optical penetration, whether these states are of acute (e.g., bacterial infection, medication side effects) or chronic origin (e.g., incipient arthritis, autoimmune disease, arteriosclerosis).
(34) 9. Improved ability to include infants and children and other vulnerable subject classes within the population of subjects that can be evaluated using NIRS-based technologies. These are individuals for whom some perturbation-based strategies may be physically impossible (e.g., Valsalva maneuver by neonatal subjects), while others may be deemed to pose unacceptable risk or would be likely to meet with poor compliance (e.g., 12-hr fasting for pediatric subjects).
(35) 10. Improved ability to monitor the mental alertness, or the peripheral-tissue oxygenation status, of people engaged in activities that involve low levels of physical activity, although frequently over an extended period, coupled with high levels of mental effort. Examples of applications in this area may include long-haul truck drivers, operators of commercial or military aircraft or ships or members of surgical teams, for early indications of fatigue.
(36) 11. Better performance and extended range of capabilities for brain-computer interface (BCI) applications. These are likely consequences of the invention making a set of previously unappreciated hemodynamic features available for analysis. Some of the many available feature classes may prove to correlate better, or more consistently or reliably with subject intent to effect the perturbation-based responses that are the current focus of most BCI efforts. Alternatively, in recognition that the goal of BCI is to infer information on a relatively short time scale, and in recognition that coordinated behaviors of the brain are not static, the considered measures may serve to identify which of several likely functional states are operational. It follows that applied training methods can be fine-tuned to recognize when these are present, thereby improving the interpretation of individual subject responses.
(37) 12. Improved routine heath monitoring advanced by use of wearable devices that support longitudinal monitoring of resting-state set-point measures. For NIRS-based measures, these devices can be applied to the cranium or to any of a number of peripheral tissues (e.g., breast, skeletal muscle, adipose). Information gained from such measures is expected to support the principal goals of precision medicine, either as a stand-alone tool or in combination with panomic methods.
(38) 13. Improved ability for deceit detection. Methods described herein provide the ability to notably expand the accessible feature space compared to existing NIRS-based neurosensing methods. This follows because, unlike the requirement for identifying network features from an array of sensors, the current method can yield such information for each sensor or combinations of sensors. Also, because the current method provides descriptions of both nodal and edge behaviors, the current method supports access to other feature class such as particular thermodynamic quantities (e.g., Gibbs free energy). These can be combined with canonical measures of network topology to provide for a set of measures that are easily supported by machine learning methods.
(39) 14. Expanded information access from alternative time-series measures that can serve to enhance the utility of these methods as currently applied. It is recognized that the inventive methods described herein can be applied to other forms of time-varying physiological measures such as ECG, EEG, MEG, ECoG, fMRI, dynamic forms of thermography, OCT, photoacoustic, holography, and other sensing methods easily extended to time-domain measures, either separately or in combination. Also expanding their utility is the understanding that for each type, the applied state definitions can be adjusted as noted herein. Similarly, expanded access to higher-order behaviors from exploring co-dependencies among the network adjacency matrices, as well as from access to an expanded set of thermodynamic and network topological measures, can also serve to enhance all of the considered uses described herein
(40) 15. The methods described herein can be extended to improve capabilities that explore other time-dependent processes having non-biological/medical uses. One example is the exploration of econometric time-series data. Here we expect that, similar to behaviors seen in the exemplary data considered herein, patterns identified in correspondingly derived econometric feature spaces (i.e., adjacency matrices) derived from time-series measures will similarly prove sensitive to the influence of underlying drivers. Efforts to quantify the impact of drivers has long been appreciated by this community. For instance, often considered by this field is the method of Granger Causality, which seeks to identify the forecasting influence of one time-dependent process (e.g., trends in oil production) on another (e.g., trends in airline or automobile use).
(41) In other focuses of econometric modeling, attention is directed to network influences [51]. For instance, often explored are how prices, information, and quantities reverberate in a particular social or economic system. The key advantage offered by the methods of the current invention is the ability to better blend information from scalar measures (i.e., information, prices, quantities) that often serve as input to network measures with recognized dynamic processes (e.g., forces affecting capital markets, stock/bond prices, etc.), thus enabling enhanced network descriptions that normally would not be easily defined.
(42) 16. For the mentioned capabilities and those related as a consequence of their impacting oxygen homeostasis, it is also appreciated that the metrics outlined by Eqs. (1)-(19), and others listed in the section on Description of Alternative Embodiments and those described, but not expressly listed, including the goal to determine various “hidden” coefficients that are normally accessible from solutions to inverse problems that follow from methods suitable for exploring network problems and their associated rules (e.g., use of formal language theory, (FLT)), as well as features identified from findings listed in the included Figures, can be expressed to appreciate trends in these measures from repeat measures that, when compared to group-level measures of healthy subjects, or to themselves, can serve to indicate the presence of anomalous behaviors.
(43) It is also recognized that these trends can be acquired from wireless wearable devices equipped to perform time-series Hb measures and linked to cloud computing environments. This arrangement can serve to identify anomalous trends that may warrant immediate attention (e.g., call to emergency services) or additional follow-up. It is further recognized that the ability to obtain the information detailed herein from a variety of tissue types and time-dependent measures supports generation of Big-Data sets, whose group-level behaviors can be mined using various machine learning methods.
(44) As noted elsewhere in this invention, all of the above biomedical and health assessment uses can be accomplished by adoption of a variety of sensing formats (e.g., contact, non-contact, endoscopic), whose primary signal may or may not be subsequently transduced into another form as accomplished by photoacoustic or fluorescence/bioluminescence phenomena.
Method of Implementing Preferred Embodiment
(45) 1. Relationships Among Co-Varying Elements of the Hb Signal:
(46) Covariation among state variables in a dynamical system can be appreciated by examining state-space plots. This may be accomplished in the case of Hb time series measures by plotting the time-varying changes in oxyHb against concurrent variations in deoxyHb (i.e., ΔoxyHb vs. ΔdeoxyHb). While quasi-steady-state changes in component values are defined relative to their respective temporal means in exemplary results presented in this application, the described method is not dependent on using the temporal mean as the reference condition.
(47) We can additionally represent relative changes in the dependent Hb-signal components (i.e., totalHb, HbO.sub.2Sat, HbO.sub.2Exc) within the ΔHb state-space plot, by introducing associated axes whose orientations with respect to the primary axes follows directly from their definitions. Thus, concurrent changes in totalHb levels (ΔtotalHb) can be appreciated by introducing an axis rotated by 45 degrees counterclockwise about the origin with respect to the ΔdeoxyHb axis. Appreciation of co-variations in ΔHbO.sub.2Exc can be gained by introducing a fourth axis orthogonal to the ΔtotalHb axis. By adding a line demarcating (ΔdeoxyHb, ΔoxyHb) pairs that correspond to hemoglobin oxygen saturations above and below the temporal mean value, ΔHbO.sub.2Sat values can also be determined from the plot.
(48) 2. Finite-State Network Representation of the Hb Signal:
(49) Depicted in
(50) A novel aspect of the present application is the exploration of different pairings of Hb signal components as primary axes, in addition to the
(51) 3. Quantification of Inter-State Transition Coefficients Comprising the Network Adjacency Matrices:
(52) Every reconstructed image time series has the form of a N.sub.t×N.sub.v matrix, where N.sub.t and N.sub.v are the numbers of measurement time frames and image voxels, respectively. In turn, each voxel occupies exactly one of the ten Hb States at every time frame. Using i and j for the time and space variables, respectively, s.sub.ij, denotes the State of the j.sup.th voxel in the i.sup.th time frame, and is the ij.sup.th element of the N.sub.t×N.sub.v matrix S.
(53) The method described in this application for counting transitions differs from that of prior applications, in that here we compare the Hb State in each time frame to the one immediately following it. A consequence of this “synchronous” definition is that, here even the case where a voxel is in the same state at successive times frames is counted as a transition, with the result that 100 transition types are defined, in contrast to 90 in prior applications [45].
(54) In the method of the preferred embodiment, the transition matrix T is a linear combination of two time-shifted copies of S:
T.sub.1:N.sub.
(55) Thus all values in the ranges of 1-10, 11-20, . . . , 91-100 correspond to transitions from State 1, 2, . . . , 10 (the nomenclature we adopt is that this is the pre-transition State), while all values ending in 1, 2, . . . , 9, 0 correspond to transitions into State 1, 2, . . . , 9, 10 (the post-transition State). We also note that the dimensions of T are (N.sub.t−1)×N.sub.v (just as a n-story building has n−1 inter-story staircases), and that the interval between the i.sup.th and (i+1).sup.th time frames constitutes the i.sup.th time step.
(56) 3.1. Computation of Probabilities for Transitions Between States
(57) The absolute transition count for a given subject and the k.sup.th transition type, k=1-100, is obtained by first generating the matrix U.sub.k, whose ij.sup.th element is:
(58)
(59) Summing U.sub.k over its spatial dimension and transposing yields C.sub.k, the 1×(N.sub.t−1) matrix of type-k transition counts, whose i.sup.th element is:
(60)
(61) Performing the computation in Eq. (3) for all 100 transition types produces C, a 100×(N.sub.t−1) matrix of transition counts, where C.sub.k is the k.sup.th row of C.
(62) To reduce the information in C to a form amenable to inter-subject comparison and quantitative analysis, we first sum over the temporal dimension, to produce the 100-element transition-count vector c, whose k.sup.th element is:
(63)
and N.sub.TS=N.sub.t−1 is the number of measurement time steps. Each ck value is directly proportional to the measurement duration. Accordingly, for inter-session or inter-subject comparisons we normalize c to the sum of all values in c:
(64)
(65) The k.sup.th element of (dimensionless) P is the probability for the k.sup.th transition type, in units of percent.
(66) 3.2. Computation of Pre-Transition and Post-Transition Dwell Times:
(67) There are ten transition types that correspond to a voxel being in the same Hb state in successive time frames (using the single-number indexing defined in Eq. (1), they are types 11n−10, where n=1-10). The term we adopt to describe occurrences of these transition types is that the voxel “dwells in” State n during that time step. For each transition type k, two distinct average dwell times are extracted from transition matrix T. These are the mean number of time frames that voxels dwell in the pre-transition State (s.sub.1=┌k/10┐ where the“ceiling function” ┌x┐ is the smallest integer≥x) prior to transition k, and the mean number of frames that they dwell in the post-transition State (s.sub.2=k−10(s.sub.1−1)) following it. We introduce the quantities (n.sub.s.sub.
(68)
(69) where (U.sub.k).sub.ij (Eq. (2)) is 1 (0) if a type-k transition does (does not) take place in the j.sup.th voxel in the i.sup.th time step, and c.sub.k (Eq. (4)) is the total number of type-k transitions in the image time series. The two dwell times have different time-step summation limits in the index-i summations in Eq. (6), because pre (post)-transition dwell time cannot be evaluated for transitions that occur during the first (last) time step.
(70) For the ten s.sub.n.fwdarw.s.sub.n transition types there can be two or more consecutive occurrences of the same type, and this would produce multiple values of n.sub.s.sub.
(71) Each dwell time computed via Eq. (6) is a grand-average (GA) quantity, in that averaging is performed simultaneously over the spatial and temporal dimensions. However, inspection of large numbers of measurement-channel time series and image time series led us to hypothesize that systematic variations in the dwell times can be present, in either the spatial or temporal dimension. To allow for further examination of these possibilities, we have developed two other summation schemes, to compute the spatial means of the (possibly) position-dependent temporal mean values and the temporal means of the (possibly) time-varying spatial mean values of the pre- and post-transition dwell times. However, except when otherwise stated, GA dwell-time values are considered in the exemplary results.
(72) 3.3. Quantification of Transition-Linked Hemoglobin-Component Concentration and -Saturation Changes:
(73) The Hb states and transitions are defined in a manner that is independent of component amplitudes, and hence of distance from the axes or origin in
(74) The starting point for the concentration- and saturation-dependent quantities is fifteen matrices, three for each component of the Hb signal, which are interrelated in the following way:
Δ.sup.2D.sub.1:N.sub.
Δ.sup.2E.sub.1:N.sub.
Δ.sup.2O.sub.1:N.sub.
Δ.sup.2S.sub.1:N.sub.
Δ.sup.2To.sub.1:N.sub.
where ΔD, ΔE, ΔO, ΔS and ΔTo denote the image time series (formatted as N.sub.t×N.sub.v matrices) of ΔdeoxyHb, ΔHbO.sub.2Exc, ΔoxyHb, ΔHbO.sub.2Sat and ΔtotalHb, respectively, while Δ.sup.2D, Δ.sup.2E, Δ.sup.2O, Δ.sup.2S and Δ.sup.2To are the corresponding concentration and saturation changes that attend each transition.
(75) Proceeding in parallel with the transition probability derivation, the analogue of Eq. (2) is:
(76)
where X is any of the Hb-signal components D, E, O, S or To in Eq. (7).
(77) Thus the U.sub.k.sup.X arrays with superscripts ‘(1)’, ‘(2)’ and ‘(3)’ contain pre-transition, post-transition, and transition-associated change data, respectively. We sum the arrays defined in Eq. (8) over position and time, and account for inter-subject variations in measurement duration by normalizing to the transition count:
(78)
(79) The (μ.sub.k.sup.X).sup.(1) parameter is the mean value, per transition, of pre-transition concentration or saturation, while (μ.sub.k.sup.X).sup.(2) is the corresponding post-transition value. We refer to ϕ.sub.k.sup.X which is the average change in Hb component X per type-k transition, as a transition flux. A related quantity called the transition mass (m.sub.k.sup.X), is the average change in Hb component X per unit of time, and is found by computing:
(80)
(81) As in the case of pre-transition and post-transition dwell times, we have developed alternative formulations for the pre-transition and post-transition mean values, and for the transition fluxes, that allow for examination of the possibility of spatial variations in the temporal means and fluxes, or temporal fluctuations in the volumetric means and fluxes. Unless otherwise noted, exemplary results consider the GA means and fluxes defined in Eqs. (9) and (10).
(82) 3.4. Quantification of Features Derived from Thermodynamic Considerations:
(83) 3.4.1. Boltzmann Energy Distribution of Transition Types:
(84) A plausible hypothesis for the observed differences among probabilities for the various transition types is that the probabilities reflect a transition type-dependence in the energy expenditures associated with the transitions. Then the dependence of energy on transition type k can be estimated by computing, for each value of k in turn:
(85)
where P.sub.k is the k.sup.th element of the transition probability defined in Eq. (5), and the exponent x.sub.k is the dimensionless quantity x.sub.k=ε.sub.k/(kT) [ε.sub.k=energy with physical units (e.g., J, kcal), k=Boltzmann constant, T=absolute temperature]. Eq. (12) can be rearranged to:
p.sub.ke.sup.−x.sup.
−p.sub.ke.sup.−x.sup.
−p.sub.k− . . . +(1−p.sub.k)e.sup.x.sup.
(86) Applying Eq. (13) to each of the k=1-99 transition types in turn (k=100 is omitted because it does not contribute independent information, since p.sub.100=1−Σ.sub.k=1.sup.99P.sub.k) yields a system of linear equations:
(87)
from which it follows that the 99 differences between x.sub.1 (and it should be noted that the transition type that we label as ‘1’ is an arbitrary choice) and each of x.sub.2 through x.sub.100 can be obtained by computing:
(88)
(89) 3.4.2. Gibbs Free Energies for Individual Transition Types and for Pre-Transition States:
(90) Applied here is a sequence of assumptions and inferences that parallels the reasoning that has been previously applied for analysis of protein-protein interaction (PPI) networks [52,53]. Thus we make the ensemble assumption that many copies of each Hb State are present at many locations throughout the tissue structure from which the measurement data are obtained, and that every type of transition occurs at multiple locations and time steps throughout the measurement period. Therefore, we can assume an ensemble of States and transition types, akin to an ideal gas mixture.
(91) For the set of ten transitions having a given pre-transition State in common, the counterpart of the free energy defined for a specified protein within an interacting set (e.g., Eq. (1) in Ref 54) is:
(92)
where (μ.sub.10(j−1)+i.sup.X).sup.(2) post-transition mean values, for Hb component X, as defined in Eq. (9), and pwa|(μ.sub.j.sup.X).sup.(1)| is the probability-weighted average of absolute values of the associated pre-transition mean values (Eq. (9)); that is:
(93)
where the P.sub.100(j−1)+i are elements of the transition probability defined in Eq. (5).
(94) The counterpart of Eq. (16) for the case of free energies of individual transition types is simpler, in that here there is no need to compute an averaged value for the pre-transition Hb-component mean. Instead, we have:
(95)
(96) We note that free energies, at either the State or transition-type level, can be computed for any quantity that has distinct pre-transition and post-transition values. For example, the transition dwell times (Eq. (6)) are appropriate inputs for computation of free energy values using either Eq. (16) or Eq. (18).
(97) It also should be noted that here, as in the cited work on PPI networks, the quantities defined in Eqs. (16) and (18) have the same units as the considered network feature (i.e., % for ΔHbO.sub.2Sat, M for the other Hb-signal components, time steps for dwell times), rather than conventional energy units. This is not cause for concern, since the values computed using Eqs. (16) and (18) are called Gibbs free energies only by analogy to the case of ideal-gas mixtures from classical thermodynamics [https://www.tf.uni-kiel.de/matwis/amat/def_en/kap_2/advanced/t2_4_1.html]. However, evidence is presented to show there likely is a proportionality between the computed “energy” and some type of true physical energy.
(98) 3.4.3 Network Entropies for Individual Subjects and for Subject-Group Means:
(99) Transitions are observed (although with different probabilities) from every State to every State. Equivalently, the States are nodes of a fully connected network, with an edge connecting every pair of nodes. Therefore, every node has the same topological degree (i.e., the number of other nodes to which a specified node is connected) of 9, and an explicit computation of the node-degree entropy S (e.g., Eq. (2) in Ref. 55) will always produce the trivial result S=0. However, the same mathematical formula:
(100)
still can be used to compute a meaningful entropy value, by interpreting the summation index k as denoting all possible values for a specified network edge weight, and p(k) as the probability distribution for the selected weight [56]. In contrast to Gibbs free energy, an entropy value can be computed for any kind of network weight, whether the weight values are properties of individual network nodes (e.g., Hb-component mean values, dwell times) or of transitions between pairs of nodes (e.g., transition probabilities, fluxes); a trade-off is that only a single entropy value is obtained for the network. Exemplary entropy values have been computed for each of the state-transition and Hb-component features described in sub-sections 3.1-3.3.
(101) Experimental data used in the exemplary computations are divided into four sub-groups, corresponding to the tumor-bearing and contralateral unaffected breasts (i.e., T and U, respectively) of women with breast cancer, and the left and right breasts (L and R, respectively) of women who did not have breast cancer at the time of measurement. For a selected type of network weight (i.e., w), the entropy computation for each individual subject was performed by first summing the values of for each set of 10 transition types having the same pre-transition State (i.e., W.sub.j=Σ.sub.i=1.sup.10|w.sub.10(j−1)+i|), then combining the W values for both breasts into a single set and identifying the smallest (i.e., W.sub.min) and largest (i.e., W.sub.max) values overall. The range from W.sub.min to W.sub.max was then divided into a finite number of equally spaced bins, and the fraction of W values in each bin was evaluated, for each breast separately. (For exemplary-results computations the number of bins was 9, to mirror the number of mathematically possible network-degree values in a 10-node network; but we recognize that the bin number is an adjustable parameter.) The bin-dependent fractions are used as the p(k) values in Eq. (19), to compute a network entropy value for each breast and the selected network weight.
(102) The approach taken to compute network entropies from group-mean network weights is similar to the individual-subject method; the difference is that here the W values for all four groups—L, R, T and U—are combined for the purpose of determining W.sub.min and W.sub.max. Consequently, the group mean-based entropies are not expected to equal the inter-subject means of the individual-subject values.
(103) 3.5. Biomarker Utility Validation:
(104) It is understood that the “Method of Implementing Preferred Embodiment” can generate multiple classes of adjacency matrices having dimensions of at least 10×10, along with a variety of other features having well-defined structures, for each set of specified State definitions and each selected class of time-dependent measures. It is further understood that, while the processing strategies employed herein consider summations over the space and time dimensions, data reduction strategies that retain spatial or temporal resolution also can be applied. Thus, it is recognized that the applied methods are capable, in the limit, of generating arbitrarily large coefficient spaces. Further, many of these features are disease sensitive, as evidenced in exemplary findings presented below.
(105) For those skilled in the Art, it is recognized that a variety of Artificial Intelligence-Machine Learning algorithms are available for identifying which classes of coefficient measures offer useful disease detection or monitoring, or, more generally, which classes provide the most accurate and specific measures of any biological property of interest. For instance, it can be expected that multivariate data exploration/reduction/visualization tools that were originally developed to process data sets comprising two or more types of 'omics data [56 a] will be extendible to data sets that include one or more of NIRS and other forms of non-invasive measure, along with, optionally, conventional medical-test results, biopsy data, one or more types of 'omics data, etc. It is further understood that such methods can be implemented via three basic strategies; unsupervised, reinforcement or supervised learning approaches each of which can employ a variety of computational methods (e.g., support vector machine, various forms of deep learning, discriminant analysis, among others [56b]). Supporting on-demand longitudinal monitoring, the specific sensing approach employed herein offers notable practical advantages that provide for one or more targeted intact-tissue measures. Offering access to an arbitrarily large coefficient space, the noted methods are well positioned to identify optimal biomarker performance either for stand-alone non-invasive time-series measures, or in combination with varied panomic data. Identified biomarkers can be applied with the goal of discriminating the impact of lifestyle choices or for the detection or monitoring of chronic diseases. Additionally, as described by methods outlined in the Alternative Embodiments, that include evaluation of any class of physiological time-series measure for which any of a multitude of possible state-definitions can be applied, allow access to multiple representative network and thermodynamic measures, many of which are otherwise deeply hidden.
Exemplary Data for the Preferred Embodiment
(106) Here we report group-average findings obtained from subject groups, comprising women who are and are not affected with unilateral breast cancer, that evaluate the coefficient types defined above. To assist comprehension of these data, we begin by describing subject preparation and data-collection and data-processing methods used, although these are not essential parts of the invention.
(107) 1. Diffuse Optical Tomography: Optical time series measures of the breast were acquired using a custom-made, high density tomography system [25]. Notable capabilities of this unit include the capacity to examine both breasts simultaneously while, if desired, exposing the breast to concurrent defined viscoelastic deformations. The illumination-detection scheme employed a dual-wavelength laser source (760, 830 nm) that was time-multiplexed to allow for simultaneous recording of light intensities from all elements of the sensing array with a scan rate of −2 Hz. In all, each sensing head contains 64 dual-wavelength sources and 32 detector elements that are evenly divided within a two-stage arrangement.
(108) 2. Subject Preparation: System operation supports examination of the breast while the subject is comfortably seated. Having a hinged arrangement, the top portion of the sensing array can be adjusted to allow for controlled contact in an anatomically conforming manner. In all, sensing elements are arranged to support essentially a full circumferential measurement. Findings reported herein were derived from publicly accessible, deidentified data [57]. In all, data from 63 subjects were explored, 18 with confirmed breast cancer (6-right breast, 12-left breast, average tumor size ˜2.7 cm, range 0.5-6 cm) and 45 non-cancer subjects, 23 of whom had evidence of various types of non-malignant pathologies in one breast or in both. A more detailed description of enrolled subjects is given in [4]. It is worth mentioning that findings reported here involve the same subject groups as in [4] and exploration of the same data. Different are the methodologies applied for data analysis.
(109) 3. Data Collection: Following initial setup, automated system calibration was performed to identify optimal gain settings. Subsequently, resting-state measures were acquired for a period lasting ˜5-10 minutes.
(110) 4. Data Preprocessing: Data were screened for evidence of degradation of signal quality caused by excessive signal attenuation by very large breasts or by poor skin-contact for very small breasts, using methods previously described [4]. To avoid introducing bilateral signal bias, channels excluded from one breast were also excluded from the other, resulting in symmetric data sets. Also, to avoid under-sampling biases, only measures from women that included at least 60% of all data channels were considered. Experience showed that operating limits are breasts having cup sizes varying from B to DD.
(111) 5. 3D Image Reconstruction: Tomographic reconstructions were achieved by first normalizing measured signal intensities to the respective temporal mean values of each data channel, then solving a system of linear equations using a modified perturbation formulation based on solutions to the diffusion equation [58,59]. Computed wavelength-dependent absorption coefficient values were subsequently transformed to yield spatial maps of the time-varying components of the hemoglobin signal. This produced five sets of maps for each breast, corresponding to spatiotemporal variations in the independent and dependent Hb components.
(112) 6. Evaluation of inter-breast differences for subjects with unilateral breast cancer: Here we use the generic symbol Y.sub.ij to denote any of the node-weight or edge-weight network features. For any transition type, each study subject has distinct values of Y.sub.ij for the left and right breast (i.e., Y.sub.ij.sup.l and Y.sub.ijr, respectively). To generate group-mean metrics and test statistics for the beast-cancer subjects (e.g.,
Y.sub.ii.sup.t(q)=Y.sub.ij.sup.l(q),Y.sub.ij.sup.u(q)=Y.sub.ij.sup.r(q), (20)
where Y.sub.ij.sup.t and Y.sub.ij.sup.u are the feature values for the tumor-bearing and unaffected breast, respectively, and q is the subject index. For subjects having right-breast tumors, however, we cannot simply equate Y.sub.ij.sup.t to Y.sub.ij.sup.r and Y.sub.ij.sup.u to Y.sub.ij.sup.l, as that would confound tumor effects with any intrinsic left-right asymmetries that may be present. Instead, we compute:
Y.sub.ij.sup.t(q)=Y.sub.ij.sup.r(q)+
where
(113) 7. Hb Feature Sensitivity to Short Time-Scale Behaviors: One of the criteria for the preferred data collection strategy is to apply a data sampling rate on a time scale at least comparable to those for homeostatic control mechanisms in the first (i.e., fastest) level of the three-level hierarchy (e.g., 1-2 sec), which are sensitive to prevailing oxygen levels. If this criterion is met, then evidence of controlled blood oxygenation, and of the expected disease-dependence of that control should be observable in the measured hemoglobin signal.
(114) Shown in
(115) 8. Information Pertaining to Homeostatic Control Mechanisms in Network Weights:
(116) Apart from the notably different aspect ratios in the
(117) a. Background; Review of Relevant Previously Reported Findings:
(118) An informative way of displaying network-weight data for a selected individual feature is in the form of an adjacency matrix; in this format, the column index (i.e., numbers displayed along the horizontal axis) for each transition type is its pre-transition State, the row index (i.e., numbers displayed along the vertical axis) is the post-transition State, and the feature values (i.e., numbers displayed along the color bar) are indicated by the colors applied to the 100 small squares in the 10×10 array [45].
(119) Adjacency matrices for a variety of network weights are shown in
(120) b. Demonstration of Non-obvious Co-dependences Between Pairs of Network Features:
(121) Inspection of adjacency matrices, even when they are displayed side by side as in
(122) c. Sequence of Data Points is the Same in All States: Interpretation:
(123) Closer inspection of
(124) The values plotted here are the ratio of the original transition probability matrix (for the T, U and L group means) to a copy of the same matrix in which rows 6-10 are interchanged with rows 1-5. The consequence of the row exchange is that every value plotted in
(125) Also revealed by the ratios plotted in
(126) d. Nonlinear Functional Forms Identifiable in Transition-Spanning Co-dependences:
(127) The sort of co-dependency analysis depicted in
(128) An example of the type of co-dependent influence that can be revealed is shown in
(129) Our initial examinations of co-dependencies considered all possible (n=133) pairings of the transition probability, dwell time (i.e., state-transition properties), flux and pre- and post-transition mean value features (i.e., Hb-component properties) described in “Method of Implementing Preferred Embodiment.” Inspection revealed that in most cases the distribution of points did not reveal evidence of distinctive structure, while others had dependences with complex forms. In the minority of cases where hyperbolic relationships similar to those in
(130) Evidence of symmetry also is present in the plot for any of the reduced set of 10 pairings showing hyperbolic dependences. In particular, inspection of
(131) Depending on the specific pairing of features considered, it may be possible to fit a hyperbola to each set of points having the same color-and-fill (i.e., the same pre-transition State), as in
(132) e. Reduction of Hyperbolic Co-dependences to (Disease-Sensitive) Setpoints:
(133) Once it is known that a given set of points lie on a hyperbola, all of the information in that function can be extracted from a small number of parameters. For example, a complete hyperbola can be constructed from just a knowledge of the coordinates of the vertices and foci. That is, plots such as those in
(134) Plotted in
(135) Shown in
(136) Whereas setpoints are commonly identified in clinical practice, and are considered a consequence of network behaviors, the details of such networks are almost always hidden. In contrast, the methods described herein allow access to at least a portion of the network details associated with such behaviors. It is further identified, that such details can have distinctive structure that is shown to vary across different feature classes. A separate noted advantage gained from identifying the described setpoint behavior is its significant data-reduction effect. Here we demonstrate that an entire 3D time series measure can be reduced to a just few pairs of coefficients, of which whose amplitudes are disease sensitive.
(137) f. Utility of Thermodynamic Parameters Computed from Hemodynamic-Network Features:
(138) In this section we explore thermodynamic features accessible from the network descriptions. Being theoretically grounded, the character of this approach differs from the preceding data-driven analyses. To render the theoretical formalism more concrete, we begin with a brief consideration of its theoretical underpinnings.
(139) Among the noteworthy findings from our examination of the various network-feature pairings (here, let X and Y denote the adjacency matrices for a selected feature pair) is that in some cases the sum, over all rows i and columns j, of products X.sub.ij*Y.sub.ij is nearly zero. This orthogonality property suggests that (i.e., is a necessary condition for) the network dynamics may be governed by Tellegen's theorem [46,47]. However, it is necessary to rule out the possibility that the orthogonality is an incidental consequence of the fact, which becomes apparent on inspection of adjacency matrices such as those in
(140) A finding that demonstrates the potential for clinical utility in computed thermodynamic features, which does not depend on the validity of the preceding understanding, is the patterns of individual transition-type Gibbs free energies shown in
(141) Examination of computed network entropies (S) gave disease sensitivity and specificity findings qualitatively similar to those from ΔG. (It will be recalled, however, that a single value for ΔS is computed for each breast. Each scalar S value thus is a composite of information for all transition types, whether individually disease sensitive or not.) Of the 18 network parameters evaluated (i.e., 1 transition probability, 2 dwell times, 5 Hb-component fluxes, and 10 Hb-component pre- or post-transition mean values), the majority (11; median t-test p-value 3.0×10.sup.−4) yield significant inter-breast differences for the breast-cancer group, which were notably larger than the corresponding values for the non-cancer control group (7; median p-value 0.023).
(142) Returning to the consideration of
(143) An example of the considered re-labeling is shown in
(144) Referring back to the adjacency matrices shown in
(145) When prior examinations of co-dependences between the 133 pairs of network weights were extended to include the thermodynamic features, observed in all but two instances were complex functional forms, both in the complete set of 100 transition types, and in subsets corresponding to individual pre-transition States, post-transition States, or transition Classes. One exception is the plot of individual-transition ΔG(ΔtotalHb) vs. ΔG(ΔHbO.sub.2Sat) shown in
(146) A closer inspection of
(147) We also note, with more than passing interest, that among the 10 feature Class pairings of ΔG measures, it is only the pairing between changes in blood volume (ΔtotalHb) and Hb oxygen saturation that was found to exhibit a well-defined, in fact hyperbolic, behavior when explored as a thermodynamic quantity, in contrast to the multiple sets of hyperbolic behaviors seen in pairings of ΔtotalHb and the other Hb forms when considered as native chemical species (
(148) The preceding two examples offer evidence that Class-labeled co-dependences reveal distinctive structure that is qualitatively different from the hyperbolic dependences seen in their transition type-labeled counterparts. Accordingly, these findings have motivated a more systematic search of Class-dependent representations involving co-dependent behaviors among the various adjacency matrices which, as shown in the next section, identifies an example wherein clear evidence of hyperbolic behavior is observed. However, in contrast to the character of hyperbolic behavior involving only Hb components, we show such behavior arises in a composite metric that combines information from both Hb-component and Hb-State network features.
(149) g. Evidence for Processes Exhibiting Michaelis-Menten Kinetics:
(150) As noted, the presence of a hyperbolic functional form in co-dependency results suggests that enzyme-like behavior underlie the observed macroscopic relationships. Consequently, we re-examined the co-dependences between transition probability, which can be regarded as an analogue for substrate concentration (i.e., there are high and low abundances of transition types that have large and small probabilities, respectively), and the fluxes for all Hb components, which can be analogized to reaction velocities. In addition, we considered a sixth type of “flux,” defined as the difference between the post- and pre-transition dwell times (just as the flux for a given Hb component is the difference between its post- and pre-transition mean values (Eqs. (7)-(10))). While none of the univariate cases reveals more than a suggestion of a hyperbolic form in the plots of flux (or |flux|) vs. probability, a hyperbolic relationship becomes apparent when the quantity plotted on the y-axis is the amplitude of a vector formed from at least two fluxes. An example, in which the considered vector is formed from the ΔHbO.sub.2Sat flux, ΔtotalHb flux, and dwell-time-difference, is shown in
(151) To strengthen the argument that the amplitude-vs.-probability trend is a hyperbola of the type that is most frequently found to describe the relationship between enzyme velocity and substrate concentration (i.e., Michaelis-Menten kinetics), we have plotted 1/(vector amplitude) vs. 1/(transition probability), because this transform (i.e., Lineweaver-Burk (LB) plot) produces a linear trend. We further note a transition-class dependence to the strength of the hyperbolic relationship: the Class 3 (cyan), 4 (magenta), and 5 (blue) data points all have the same enzyme-like dependence, while the Class 2, 1 (shown in inset) and 0 points (not shown) progressively deviate from it.
(152) The striking linearity observed (r>0.99) is made even more remarkable by the recognition that the plotted data values are composites taken from subjects having large ranges in age (CA 53.8±11.1; non-CA 49.8±11.2) and BMI values (CA 32.3±7.9; non-CA 32.2±5.6), indicating that the observed trends are determined by strongly conserved biological phenomena.
(153) The most prominent quantitative difference between the LB plots for the cancer and non-cancer subjects is that the apparent-V.sub.max is notably higher for the former group, with little change in the apparent-K.sub.M parameter. We note that this difference is consistent with well-known aspects of tumor physiology, wherein NO levels are elevated, and this factor is known to increase the V.sub.max of soluble guanyl cyclase, which serves to drive vasomotion in vascular smooth muscle and can be expected to impact observed macroscopic measures. Thus we find that similar to the derived setpoint behaviors accessible from determinations of the previously considered vertex and focus measures, here we gain access to yet another form of setpoint behavior, but whose particulars and trends are distinct.
(154) Even with the presented evidence, it is natural to question how a macroscopic sensing approach could be capable of identifying data trends that are suggestive of enzyme-like behaviors. Our attention is directed to two principal elements of the considered methodology: data sampling rate, and signal averaging. For the former, we employed a sampling rate (2 Hz) that is at least as fast as needed to appreciate the Nyquist limit of the highest frequency signal (cardiac signal) and avoid notable signal aliasing. In practice, we recognize that faster sampling rates are routinely available from most NIRS-based sensing systems.
(155) At these sampling rates, signal classification in accordance with a State definition has the effect of sampling elements of a temporal derivative. Normally, individual measures of this feature could be expected to vary notably, given physiological background behaviors. However, and because our attention is directed to State behaviors, these fluctuations can be expected to be extensively damped as a consequence of spatiotemporal averaging, wherein the number of occurrences of a given transition type often exceeds 50K. Accordingly, one advantage of a methodology aimed at characterizing State behaviors is the enormous statistical power that can be gained in determining systematic trends in the behavior of the temporal derivative. Of course, such averaging assumes that information content of the signal being averaged is substantially similar throughout the measurement period, which we hold as correct given that our measures are made under the resting state.
(156) We further argue that a relationship between precise measures of elements of the temporal derivative of a physiological signal and underlying enzymatic behaviors that serve to generate the macroscopic behavior is also expected. Even so, this raises the question of why it should be possible to observe well defined enzyme-like behaviors.
(157) Here our attention is directed to the many transition types that we take as reflecting the varied microenvironments of a bulk tissue. As noted above, and with some liberty, we apply a first-order biological interpretation to the adjacency matrices for State transition probability as being proportional to “substrate concentrations,” and to flux measures as representing a “composite of enzyme-like behaviors.” While the latter analogy seems plausible, the former, on first glance, seems less evident given that the more obvious candidate to assume the role of a “substrate concentration” would be the mean values of the Hb-components themselves. However, we note that because the State transition behavior itself is almost certainly a consequence of enzyme action, it seems reasonable that the likelihood of a transition occurring at all should in some way be proportional to an associated prevailing substrate level.
(158) We further note that evidence of enzyme-like behavior among the Hb-component pairings that include ΔtotalHb as one element of the pair (
(159) It is this understanding that we argue logically supports extension of the methods detailed herein to other forms of physiological time-series measures. In the case of bioelectric phenomena, it is known that the signal amplitude is proportional to voltage-dependent ion-channel activity. Finer details that include the frequency dependence of such behaviors, which in the case of brain activity is strongly affected by prevailing connectivity patterns, among other factors, suggest that State definitions that recognize the primary frequency components of this signal, along with the expectation that each of these will vary about a temporal mean value in the steady state, indicates that, similar to the varied transition probability patterns seen for the hemodynamic measures, analogous phenomena are likely to occur with bioelectric measures. Different here, however, is the number of assignable states.
(160) Unlike the more limited number of plausible states arising from the five recognized components of the Hb signal, the same number of states for bioelectric phenomena will yield 32 states (2.sup.5) along with corresponding adjacency matrices having dimensions of at least 32×32. Apart from this, all other assignable phenomena such as pre- and post-transition dwell times, similar pre- and post-transition mean amplitude of the frequency components, along with the associated flux and mass measures, directly follow.
(161) The suggestion that co-dependent phenomena among the various adjacency matrices may prove highly structured (e.g., hyperbolic, and hence yield setpoint measures), we argue also follows for the same reasons offered to account for such behaviors in the case of Hb-signal measures: i.e., the applied State definitions reflect a large range of tissue microenvironments, and hence corresponding adjustments in the “substrate levels” should influence composite enzyme-driven reactions that ultimately impact macroscopically observable behaviors.
(162) The reverse argument, which considers the myriad of enzymatic reactions occurring in cells and conclude that this multiplicity should serve to significantly limit any reasonable assignment derivable from structured macroscopic behaviors, overlooks the fact that while the number of enzyme types in tissue is truly large, the number that can be expected to have a notable impact on specific forms of observable phenomena is much smaller. For instance, it has long been recognized that force generated by muscle contraction is directly proportional to the number of actin-myosin bridges formed, coupled with the hydrolysis of ATP by myosin-ATPase.
(163) This recognition calls attention to factors affecting states of health and chronic disease, and to expected actions of OS, which is a known driver for changes in genetic and, more commonly, epigenetic expression. Accordingly, a key thrust of this invention is to build on the wealth of experience gained from understandings derived from panomic measures. As such, we believe that the wealth of biomarkers accessible from the applied methods are well positioned to complement existing precision-medicine objectives, and that they potentially can serve to accomplish meaningful guidance as a stand-alone technique.
(164) As documented herein, examination of trends among pairing of coefficients involving two or more adjacency matrices, in some instances were demonstrated as representative of having a highly structured co-dependency (e.g.,
(165) h. Internal Validation of Thermodynamics-Based Features
(166) A question that particularly arises with regard to computed thermodynamic features is whether the underlying assumptions—e.g., the postulated analogies between ensembles of States and transition types, and mixtures of ideal gases—can be internally validated. (Although it is recognized that the features that are here referred to as “Gibbs free energy,” “network entropy” and “Boltzmann energy distribution” may prove to have practical utility regardless of any theoretical validation.) One approach we took, by analogy to the classical thermodynamic relationship between Gibbs free energies (ΔG) and equilibrium constants, was to determine if the pre-transition State ΔGs (Eq. (16)) are correlated with the time-averaged tissue-volume fractions in those States. Findings summarized in Table 1 show that ΔG(ΔHbO.sub.2Sat) and ΔG(ΔtotalHb), singly or in combination, have low-to-moderate correlations with the State volume fraction (V). In contrast, the combination of ΔHbO.sub.2Sat and ΔoxyHb (which singly has near-zero correlation with V) produces a strikingly positive correlation, for each of the four subject-breast categories. Plots of volume fraction vs. the best-fitting linear combination of ΔHbO.sub.2Sat and ΔoxyHb, for all four groups, are shown in
(167) TABLE-US-00001 TABLE 1 Correlations between pre-transition State volume fraction and pre-transition State Gibbs free energy (ΔG), for selected univariate and bivariate combinations of Hb-components. Pearson Correlation Coefficient and 95% CL ΔHbO.sub.2Sat & ΔoxyHb & ΔoxyHb & Group ΔHbO.sub.2Sat ΔtotalHb ΔtotalHb ΔoxyHb ΔtotalHb ΔHbO.sub.2Sat T 0.75 0.83 0.83 0.01 0.89 0.9993 [0.22 0.94] [0.42 0.96] [0.42 0.96] [−0.62 0.64] [0.58 0.97] [0.9969 0.9998] U 0.56 0.54 0.58 0.07 0.68 0.989 [−0.11 0.88] [−0.14 0.87] [−0.08 0.89] [−0.58 0.67] [0.09 0.92] [0.950 0.997] L 0.68 0.73 0.74 0.10 0.83 0.992 [0.08 0.92] [0.18 0.93] [0.20 0.93] [−0.57 0.69] [0.41 0.96] [0.966 0.998] R 0.58 0.57 0.60 0.04 0.72 0.980 [−0.07 0.89] [−0.10 0.88] [−0.04 0.89] [−0.60 0.66] [0.16 0.93] [0.915 0.995]
(168) Additional validation computations were performed to evaluate dependences between the Boltzmann energy distribution of the transition types on linear, bilinear, and quadratic functions of the fluxes and pre- and post-transition means for the different Hb components, in the expectation that if the computed energy levels in fact do correspond to physical energies between different microscopic configurations, then there will be at least one macroscopic amplitude-dependent parameter whose values are (at least approximately) determined by those energy levels. One example of a significant relationship is shown in
(169) i. Contrast Between Network-Feature Findings for Functional Imaging Data and for Random-Number Data:
(170) In recognition that many of the quantities presented in the above figures are obtained by application of an extensive sequence of data transforms (e.g., 3D-tomography, modified Beer-Lambert, computation of network adjacency matrices, thermodynamic measures), in this section we have undertaken additional control measures to explore whether such transforms, per se, can explain some of the features seen.
(171) A common approach for evaluating questions of this type is to substitute “noise” measures for experimental data. As shown in
(172) A second control study was conducted to determine whether evidence of hyperbolic features depend on subsequent data transforms to those used to generate the adjacency matrices. Here our attention is drawn to the data transforms employed to determine Gibbs free energy relationship between two Hb-components, and the LB plot which, should the trend be hyperbolic, will appear as a linear function in a double-reciprocal plot.
(173) Because both plots describe similar functional forms, should these arise from the data transform per se, then a random permuting of the input data values should not significantly alter the observed behavior. Shown in
(174) To summarize, the findings presented herein document access to deeply hidden, highly structured behaviors arising from network descriptions of time-dependent measures of the Hb signal, several of which are strongly suggestive of enzyme-like behaviors even though the applied measures are decidedly macroscopic. These behaviors give evidence to a previously unrecognized level of quantifiable homeostatic control in living tissue that is accessible from resting state measures and is disease sensitive and hence influenced by disturbances in the prevailing genomic-epigenetic landscape.
(175) As documented by findings from a representative measurement, tissue type and form of chronic disease, and the knowledge that the considered methods are easily translated to nearly all tissue classes, are favorably applied in a wide range of settings and readily support longitudinal monitoring, the described methods, with their demonstrated ability to yield varied forms of mainly independent network weights and structured behaviors providing access to setpoint measures, collectively are well positioned to advance the goals of personalized medicine. Also understood is that the methods considered herein can be generalized to other forms of time-dependent physiological measures for which we anticipate that qualitatively similar forms of structured, yet hidden, behaviors can be described. As outlined subsequently, we also recognize that the above-described methods can be extended in various ways that support the previously identified medical and non-medical applications.
DESCRIPTION OF ALTERNATIVE EMBODIMENTS
A. Extensions and Generalizations of Specific Preferred-Embodiment Features
(176) The invention is not dependent on the specific values assigned to any of the parameters, and can be modified in any of the following ways, which can be expected to enhance its generalizability and to support its potential for advancing personalized health evaluation.
(177) 1. The number of Hb-States defined can be either less than or greater than 10, and a state corresponding to any specifiable angular sector of the space depicted in
2. The definition of a Hb-State can take distances of points from the coordinate-system origin into account, in one or more coordinate directions, in addition to the angular information (e.g., State A is defined as the set of all points lying between rays inclined at angles of B degrees and C degrees with respect to the horizontal axis, with values for ΔdeoxyHb of at least D mol-L.sup.−1 and at most E mol-L.sup.−1, and with values for ΔoxyHb of at least F mol-L.sup.−1 and at most G mol-L.sup.−1).
3. A reference point other than the resting-state temporal mean value can be used for defining temporal fluctuation values (e.g., ΔtotalHb), i.e., for defining the origin of the coordinate system. Different reference points may be chosen for different components of the Hb signal.
4. Transition counts may be based on the Hb-State of the v.sup.th voxel in the t.sup.th time frame and at a subsequent fixed number n of time frames, with n>1. In this case the time interval nΔt may be taken as an additional control parameter, and a count-vs.-n function generated [60].
5. The transition counts for each post-transition Hb-State can take into account not only the current time frame but also the one before that. Generalizing, for any positive number k, k=1, 2, 3, . . . , the k time steps prior to the current one may be considered. As an example, instead of a single count of all transitions from State 1 into State 2, an alternative embodiment could perform ten separate counts, corresponding to the ten states that may have preceded State 1: 1.fwdarw.1.fwdarw.2, 2.fwdarw.1.fwdarw.2, 3.fwdarw.1.fwdarw.2, 4.fwdarw.1.fwdarw.2, etc.
6. The method used to count transitions can be based, not on a fixed number of time frames, but on the variable number that elapses between each change from one (pre-transition) Hb-State to a distinct other (i.e., post-transition) Hb-State, in which case the number of possible transition types decreases from 100 to 90 [61].
7. Transition counts need not be evaluated at the level of individual voxels, but may consider 2 or more voxels defining a region on either an anatomical (e.g., physically contiguous) or functional basis (e.g., all have initial values of ΔtotalHb and ΔHbO.sub.2Exc within specified ranges). As multiple voxels need not all be in the same Hb-State, rules would be specified for determining which pre- and post-transition States to count (e.g., the median State-value for all voxels in the defined cluster) and for when to count them (e.g., after one or more fixed values of n, or after a majority of voxels in the cluster have undergone a single transition from their initial State to a distinct other State).
8. The spatial unit over which States and transitions are defined need not be voxel-based, and none of the mathematical operations described herein pre-suppose or require reconstruction of volumetric images from the measurement data. All mathematical steps may be performed directly on data for a single measurement channel defined by one light source and one detector, or for multiple measurement channels or, alternatively, one or more data channels from a bioelectric measure.
9. In the multiple measurement-channel case mentioned in 8, the channels can be considered separately, or in combinations of two or more as mentioned in 7.
10. As mentioned in 7-9, the number of defined spatial volume units may be different from the voxel count N.sub.v defined in “Method of Implementing Preferred Embodiment”. In general, the value of N.sub.v will be determined by the choice between image-based or measurement channel-based analysis, and on the choice between considering individual voxels or channels, or composites of voxels as mentioned in 7 or composites of channels as mentioned in 9.
11. In the place of constant increments, the increment added to the current value of a transition-count array element (Eq. (3)) can be a function of the current value. For example, incrementing by an amount directly proportional to the current value would be the temporal analogue of the procedure that produces “scale-free nets” [62] when it is used to assign links between new network nodes and currently existing ones. (In contrast, assigning links with a probability that is independent of the current link number, which is the analogue of the preferred-embodiment procedure, generates “exponential nets” [63]). Use of non-constant increments may be contraindicated when analysis of resting-state measurements is considered, if the start time for data collection is arbitrary. However, it could prove informative in, for example, the analysis of evolution to the steady state following an experimental perturbation.
12. The number of dimensions for the transition-count, dwell-time, mean-value, flux, etc., arrays may be increased beyond 2, in order to allow for simultaneous consideration of more than one scheme for defining the accumulation increments as mentioned in 11.
13. Multiple transition-count, dwell-time, mean-value, flux, etc., arrays may be employed, to enable separate counts of transitions occurring in different segments of the measurement time period (i.e., history-dependent measures) instead of a single integration over all time. This ability could be important for studies not performed under resting-state conditions. Even in the case of resting-state studies, it would allow, for example, for the evaluation of the hypothesis that the tissue under study passed through a sequence of physiological steady states during the measurement time course.
14. Multiple transition-count, dwell-time, mean-value, flux, etc., arrays may be employed, to enable separate counts of transitions occurring in different regions of the measured tissue volume instead of a single integration over the entire volume. This ability could be important for studies involving tissue structure known to have or suspected of having spatially heterogeneous hemodynamics. Even in the case of (presumably) homogeneous tissues, it would allow, for example, for the evaluation of the hypothesis of directed flows of information among them.
15. A capability afforded by the transition-count arrays described for the Preferred Embodiment, but not explicitly mentioned above, is that they allow for computation of transition joint-probabilities (e.g., the probability that a voxel transitions first from State 2 to State 3, and then to State 5), as desired.
16. The rules for accumulating changes in Hb-signal component levels are tied to the rule adopted for counting transitions, in the sense that the latter determines which time frames are used for evaluating increments of concentration (or percent change in saturation). However, the mathematical form of the component-value accumulation procedure is the same in all cases.
17. If a transition-counting method is adopted based on spatial regions containing more than a single voxel (for example, the approach outlined in 7), then a corresponding modification would be made to the method used to compute the concentration and percent change increments. As an example, suppose a counting method mentioned in 7 is implemented: a transition is counted when a majority of voxels in the region have undergone a single direct transition, and the regional median Hb-State-values are taken as the pre-transition and post-transition States. Then the pre-transition and post-transition concentrations (or percent saturations) would be averaged over the same subsets of voxels that determined the identities of the pre-transition and post-transition States. Other potentially useful information could be obtained by simultaneously accumulating [in a second set of arrays maintained in parallel with those defined in Eqs. (7)-(10)] the complementary changes averaged over the subsets of voxels that were in States different from those determined by the regional medians.
18. As mentioned, in addition to the grand-average (GA) formulations described in detail in “Method of Implementing Preferred Embodiment,” two summation schemes have been developed for integrating Hb-signal information over tissue location and over time. These alternatives are known as “temporal mean of the spatial mean” (TMSM) and “spatial mean of the temporal mean” (SMTM). TMSM is appropriate for situations where substantial temporal variations (e.g., large-amplitude oscillations) in the measured signals are known or suspected to occur during the measurement period, and SMTM for situations where substantial spatial heterogeneities are or may be present. Taking transition flux as an illustrative example, where the GA formula (obtained by substituting Eqs. (3) and (4) into Eq. (10)) is:
(178)
and the corresponding SMTM and TMSM formulas are:
(179)
(180) We note that the SMTM flux is approximately equal to the GA flux if Σ.sub.i=1.sup.N.sup.
(181) The dwell time and pre- and post-transition mean value features have TMSM and SMTM formulations, which differ from their GA counterparts in the same manner as do the flux variants. (And as a consequence, the computed values for features such as Gibbs free energy vary according to which mean-value formulations is used to generate the input, although the formulas used to compute said features are the same in every case.) In contrast, values of the transition probability and transition mass features are independent of the summation scheme used.
(182) 19. While three methods of grouping transition types are explicitly mentioned in preceding sections (i.e., all types lying in the same adjacency matrix row, column, or strip parallel to the main diagonal of), none of the mathematical operations or methods of analysis is restricted to those ways of defining transition-type categories. Any other rule, however motivated, for assigning two or more transition types to a group also can be applied, and the numbers of transition types per group may be either equal (e.g., the ‘same pre-transition State’ and ‘same post-transition State’ groupings) or unequal (e.g., the ‘same diagonal’ groupings).
20. The number of network features considered in a co-dependency analysis is not limited to two. Any number of features may be incorporated, comprising any permutation of Hb-signal components, features that are and are not functions of Hb-signal component levels (e.g., transition flux and transition probability, respectively), edge-based and node-based features (e.g., flux and post-transition dwell time, respectively), and pre- and post-transition values.
21. The weighted-network entropy feature described in “Method of Implementing Preferred Embodiment” is based on the treatment found in [56] and is a straightforward extension of the conventional node entropy of an unweighted network [56]. However, the methods herein presented are not restricted to that weighted-network entropy formulation, but also could employ any of the available weighted-network entropy metrics [64].
22. The described methods for analysis of time-series data are not limited to the fNIRS measurement data employed for exemplary purposes, or to the tissue types or structures that were considered, or to hemodynamic information encoded in the measurements, but can be applied to biological time-varying signals measured from any tissue, encoded in any form of energy, and obtained using any suitable measurement technology. Thus, for example: acoustic energy (e.g., ultrasound) time series, instead of or in addition to light or other electromagnetic (EM) signals, can be the input data; the information of interest can reside in an internally generated signal (e.g., thermography, bioelectric), as opposed to one that is impressed upon an exogenous carrier (e.g., fNIRS, fMRI, acoustic imaging, OCT); EM-based techniques may make use of any suitable frequencies (e.g., fMRI, electrical impedance tomography); and, for tissues that generate time-varying EM fields (e.g., brain, heart), the data on which the various embodiments described operate may be measured by ECG, EEG, MCG or MEG time series or combinations of these and the indicated methods. Common to all of these alternative physiological measures is the understanding of a close correspondence between temporal features in the data and well-described physiological behaviors (e.g., canonical elements of the ECG waveform and cardiac function, dynamic thermographic measures that reflect time-varying features of blood flow, etc.). As noted elsewhere herein, the methods described here offer the ability to transform such measures into a set of network adjacency matrices, from which measures of co-dependent behaviors can be defined that serve to identify physiological or pathological setpoints.
23. For all of the above considered alternative embodiments (Eqs. (1)-(23)), it is understood that the native signal can be preprocessed to isolate/exclude frequency bands of interest. For instance, low-pass filtering of the represented NIRS measures could serve to remove contributions from, e.g., detectable cardiac signals.
24. It is recognized that, in contrast to multi-wavelength measurements of hemodynamic signals, other types of time-series physiological measurement generate data for which it may not be evident how that data could be resolved into two or more “components” that will then be used to define “States.” However, each type of signal possesses characteristic features that can be made to serve as the basis for a State definition. As an example, EEG signals have a well-known frequency-band structure [65], and the temporally co-varying amplitudes for multiple bands can be taken as the counterparts of the co-varying values of the Hb-signal components. In the case of fMRI, which does produce hemodynamic time-series data but is sensitive to only the deoxyHb signal component [66], in many cases components can be extracted from the peak-amplitude, time-to-peak, and full-width-at-half-maximum parameters typically used to characterize hemodynamic response functions [67]. Also, similar to the EEG case, frequency-domain approaches can be used to define fMRI components, especially in the case of resting-state measurements [68].
B. Additional Alternative-Embodiment Considerations
(183) 1. Applicability of Formal Language Theory
(184) Discrete-valued information such as sequences of Hb-State or, equivalent definitions considered above, can be formally regarded as arbitrary-length “words” in a language having a 10-“letter” alphabet (Hb-components having (+/−) values relative to temporal mean). The structures and constraints that may be concealed in these sequences are unknown a priori, and it is prudent to adopt analysis strategies that can handle arbitrary degrees and types of complexity. Work in other fields has shown that formal language theory (FLT) is well-suited for the type of situations presented by such information [69]. As an example of a goal that is conceptually straightforward, one might seek to use FLT to characterize the level in the Chomsky hierarchy that corresponds to a State- or transition-derived language, to determine a set of grammatical rules from which the sequences can be derived [70]. Such information could then be used for evaluating a research goal such as whether the hierarchy level, or the number of, or specific content of, grammatical rules differs among different subject groups. Examples of criteria that may be used to differentiate these groups include: the presence of absence of pathology, different levels of distraction (brain studies), or fatigue or stress in cases where the aim is to appreciate factors affecting overall performance in high stress environments.
(185) 2. Electrical Network Analogies
(186) While the noted understandings from FLT constitute a particular alternative approach to increasing the type and quantity of information that could be extracted from fNIRS time-series data, methods for expressing features in terms of other quantities that have biological relevance but are not directly observable are also available. Thus we acknowledge the potential to extend the network representation considered here into one where the goal is to derive coefficients from a hidden network of coefficients that reflect features corresponding to details of feedback mechanisms. In particular, we consider the framework of a DC electrical network [71], in recognition of the analogies that can be drawn between P.sub.k (or P.sub.kϕ.sub.k.sup.X=m.sub.k.sup.X) and τ.sub.k.sup.(1) to the electrical current and resistance represented in Ohm's Law. We note that the analogies drawn here between various network features and DC circuit elements are in addition to the ones that motivated the idea of treating the hemodynamic State-transition network as a thermodynamic system.
(187) Connection to the physiological processes underlying observed patterns of state transition coefficients comes from an understanding that real-world electric-circuit networks are typically based on a distribution of power sources required to drive various specialized functionalities. As our finite-state network representation considers behaviors that originate on a macroscopic scale within an inhomogeneous underlying tissue architecture, it seems likely that the factors that modulate the Hb signal will also influence features of the State-transition network in a distributed manner. Consequently, our attention has been on devising a scheme that allows for derivation of coefficients that correspond to such distributions.
(188) The definitions of τ.sub.k.sup.(1), P.sub.k and ϕ.sub.k.sup.X suggest a correspondence between τ.sub.k.sup.(1) and electrical resistance, and likewise between either P.sub.k or P.sub.kϕ.sub.k.sup.X and current. (The P.sub.k values are “transition currents” if transitions are analogized to a type of particle, while P.sub.kϕ.sub.k.sup.X values are concentration-change currents or saturation-change currents.) The different network States can be likened to nodes in an electrical network, and τ.sub.k.sup.(1) to the value of a resistor that conducts current from the pre-transition node to the post-transition node (more strictly, a resistor in series with an ideal diode, to allow for τ.sub.10(j−1)+i.sup.(1)≠τ.sub.10(i−1)+j.sup.(1)). These correspondences bring to mind at least two additional analogies to properties of electrical circuits.
(189) a) A new quantity corresponding to voltage, V.sub.k or V.sub.k.sup.X, can be defined, by applying an analogue of Ohm's law to the transition-probability and rate values:
V.sub.k=τ.sub.k.sup.(1)P.sub.k,V.sub.k.sup.X=τ.sub.k.sup.(1)P.sub.kϕ.sub.k.sup.X, (24)
where X is any of the Hb-signal components D, E, O, S or To in Eq. (7).
b) In the typical framing of electrical-network analysis problems [72], the resistances and applied electromotive forces (EMFs) are known quantities and the voltages and currents are the unknowns that are solved for. A different, inverse, version of the problem is suggested here, in that the currents and resistances are known quantities, and what must be found is an EMF or combination of EMFs that would produce the known currents, given the known structural (connectivity and resistances) and dynamic (currents) properties of the network. Assuming these quantities can be identified with a degree of confidence, then the considered approach would seem capable of amplifying our understanding of the actions of feedback mechanisms whose influences can be directly observed but whose details remain hidden.
(190) 3. Applicability of Hb-State Concepts to Enhancing Capabilities of Other fNIRS Analysis Strategies
(191) The potential to express properties of the States in terms of their sensitivities to more primitive behaviors (e.g., frequency-dependent amplitudes of time-varying signal levels, spatial heterogeneity of the amplitudes, spatial heterogeneity of the phases) is one that we have previously recognized. Here we refer to a methodology described by our group, which demonstrated that cross-domain moments (i.e., mean, variance) of spatiotemporal behaviors can be distinguished in terms of their sensitivity to these primitive behaviors [4]. While here our emphasis is on exploration of data features associated with specific transition types or Classes, we also recognize that the section of the
(192) 4. Extension to Other Conceptual Domains in Graph Theory
(193) As a separate avenue for potential future developments, we note that the range of network indices herein described spans a subset of the broader field of graph theory (which is, in turn, a subset of the even broader field of discrete mathematics). In particular, strong analogies can be drawn between the network features emphasized in the preferred embodiment (e.g., transition probabilities, dwell times, pre- and post-transition mean values, fluxes) and graph-theory methods developed for analysis of substrate concentrations and fluxes (i.e., rates of substrate production and consumption) as determined by the actions of enzymes linked together in functional networks (i.e., for metabolomics) [73,54]. Consequently, these parallels bring the expectation that algorithms used to analyze the functioning of networks into elementary flux modes [74] can also be applied to the network of Hb-flux states, to determine whether pathway preferences exist and, if so, if there are informative differences between the dominant pathways for different subject populations, or among individuals within a population.
(194) Further, the preceding can be extended by recognizing that the mathematically defined network of states that is subjected to the analysis may include other nodes in addition to the hemodynamic States. For example, a goal of the analysis may be to evaluate one or more hypotheses regarding the role of known biochemical or physiological processes in determining the observed transition probabilities, fluxes, etc. Typically these processes are the entities of ultimate scientific interest, but they are not directly observable, at least not under the same experimental or clinical conditions as the hemodynamic signal. Thus the Hb States constitute the “visible units” of the enlarged network, while states of the physiological processes (e.g., levels of specific metabolites, presence/absence of induced isoenzymes, levels of regulatory species) are the “hidden units” [75]. Connecting the network nodes would be two types of “edges”: those that, on the basis of either observation or fundamental biological understandings, are known to exist between pairs of visible or pairs of hidden nodes; and those that are hypothesized to exist between a hidden node and a visible one. One goal of the analysis considered here could be to determine—for each hypothetical pattern of edges connecting a visible node and a hidden one—edge-weight values that would allow the hidden fluxes to drive the observed ones while maintaining hidden fluxes that are plausible physically (i.e., all irreversible reactions proceed in the correct direction) and biologically (i.e., all flux magnitudes fall between established lower and upper limits) [76, 77]. A related goal could be to select among different hypotheses, based on the sensitivities of network fluxes to perturbations of the computed edge weights. The latter application is conceptually similar to established strategies used to analyze fMRI and fNIRS data for the purpose of selecting among models of effective connectivity between brain regions [78].
(195) Also understood is the availability of other, complementary set of indices for characterizing networks—e.g., average path length, diameter, average clustering coefficient, centralization, various centrality measures (degree, closeness, betweenness, eigenvector, and subgraph centrality), matching index [79]. The preferred embodiment does not explicitly consider these, for the reason that the network of Hb-signal States constitutes a complete graph, which is to say that every element in its adjacency matrix is equal to 1 [79]. As such, none of the mentioned network indices would have nontrivial values. However, meaningful network-index values can be obtained by substituting weighted adjacency matrices [76] for the more commonly considered type in which each element simply indicates the presence (1) or absence (0) of a direct connection. The preferred embodiment generates a set of quantities that can be taken as adjacency weight values: transition probability, dwell times, pre- and post-transition mean values, fluxes, masses, Gibbs free energies. Index values thus generated could be interpreted as features of the underlying networks, and then evaluated to test for the presence of informative differences between subject populations, or among individuals within a population.
(196) The preceding discussion has used the concept of networks in a qualitatively different manner from that which is considered in the field of machine learning using artificial neural networks [80,81]. We are aware that some of the data analysis efforts suggested by the above enlarged networks can become computationally challenging. It is of course plausible to use network-based (in the machine-learning sense) techniques to search for plausible, or even optimal, solutions to problems such as the previously described analysis of connectivity between the visible and hidden parts of a composite functional network.
(197) Having described certain embodiments of the invention, it should be understood that the invention is not limited to the above description or the attached exemplary drawings. Rather, the scope of the invention is defined by the claims appearing hereinbelow and includes any equivalents thereof as would be appreciated by one of ordinary skill in the art.
REFERENCES TO NEW PATENT
(198) [1] F. B. Hu, et al., “Diet, lifestyle, and the risk of type 2 diabetes mellitus in women”, N Engl J Med., 345, 790-797 (2001). [2] M. J. Stampfer et al, “Primary prevention of coronary heart disease in women through diet and lifestyle” N Engl J Med, 343, 16-22 (2000). [3] S. S. Segal, “Regulation of Blood Flow in the Microcirculation”, Microcirc. 12, 33-45, 2005). [4] H. L. Graber, et al. “Enhanced resting-state dynamics of the hemoglobin signal as a novel biomarker for detection of breast cancer”, Medical Physics 42, 6406-6424 (2015). [5] K. G. Moulakakis et al. “Hyperperfusion syndrome after carotid revascularization”, J. Vascular Surg., 49, 1060-1068 (2009). [6] X. Zhan, and R. Yu, “A window into the brain: Advances in psychiatric Mill,” BioMed Research International Article 542567, (2015). [7] M. Beauregard, “Functional neuroimaging studies of the effects of psychotherapy”, Dialogues in Clinical Neuroscience, 16, 75-81 (2014). [8] L. A. Barquero, et al., “Neuroimaging of reading intervention: A systemic review and activation likelihood estimate meta-analysis”, PLoS One, 9, Article e83668 (2014). [9] S. Calderoni et al., “Rehabilitative interventions and brain plasticity in autism spectrum disorders: Focus on MRI-based studies”, Frontiers in Neurosci. 10, Article 139, (2016). [10] J. Saliba, et al., “Functional near-infrared spectroscopy for neuroimaging in cochlear implant recipients”, Hearing Research 338, 64-75 (2016). [11] R. Sitaram et al. “Closed-loop brain training: The science of neurofeedback”, Nature Reviews: Neuroscience 18, 86-100 (2017). [12] A. Curtin et al., “Evaluation of evoked responses to pulsed-matched high frequency and intermittent theta burst transcranial magnetic stimulation using simultaneous functional near-infrared spectroscopy”, Neurophotonics 4, Article 041405 (2017). [13] J. J. Vaquero and P. Kinahan, “Positron emission tomography: Current challenges and opportunities for technological advances in clinical and preclinical imaging systems,” Ann Rev Biomed Eng 17, 385-414 (2015). [14] R. Ahmad and P. Kuppusamy, “Theory, instrumentation, and applications of EPR oximetry,” Chemical Reviews 110, 3212-3236 (2010). [15] Y. Wang, et al., “Electrochemical sensors for clinic analysis,” Sensors 8, 2043-2081 (2008). [16] T. Yoshihara, et al. “Oxygen imaging of living cells and tissue using luminescent molecular probes,” J. Photochem and Photobiol C: Photochem Rev. 30, 71-95 (2017). [17] L. V. Wang and H. Hu, “Photoacoustic tomography: In vivo imaging from organelles to organs,” Science 335, 1458-1462 (2012). [18] Y. Yamada et al., “Time-Domain Near-Infared Spectroscopy and Imaging: A Review”, Appl. Sci., 9, 1127, (2019). [19] M L Jepsen, U.S. Pat. No. 9,730,649B1, Optical Imaging of Diffuse Medium (2016). [20] S. Schuh, et al., “Imaging blood vessel morphology in skin: Dynamic optical coherence tomography as a novel potential diagnostic tool in dermatology”, Dermatologic Therapy, 7187-202 (2017). [21] S. Belanger et al., “Real time diffuse optical tomography based on structured illumination,” J Biomed Opt 15, Article 016006 (2010). [22] M. Jayachandran et al., “Critical review of noninvasive optical technologies for wound imaging,” Adv Wound Care 5, 349-359 (2016). [23] S. K. Piper et al., “A wearable multi-channel fNIRS system for brain imaging in freely moving subjects,” Neuroimage 85, 64-71 (2014). [24] J. B. Balardin et al., “Imaging brain function with functional near-infrared spectroscopy in unconstrained environments,” Frontiers in Human Neuroscience 11, Article 258 (2017). [25] Al abdi et al., “Optomechanical imaging system for breast cancer detection,” J Opt Soc Am A, 28, 2473-2493 (2011). [26] A. Mazhar, et al., “Structured illumination enhances resolution and contrast in thick fluorescence imaging,” J Biomed Opt., 15 Article 0150506 (2010)]. Non-contact, broad-area illumination methods can also be applied with the aim of employing holographic techniques [U.S. Pat. No. 9,730,649B1]. [27] D. R. Busch, et al. “Towards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics,” PET Clinics 8, 345-365 (2013). [28] P. Taroni, et al. “Non-invasive optical estimate of tissue composition to differentiate malignant from benign breast lesions: A pilot study,” Scientific Reports 7, Article 40683 (2017). [29] B. J. Tromberg, et al., “Predicting responses to neoadjuvant chemotherapy in breast cancer: ACRIN 6691 trial of diffuse optical spectroscopic imaging,” Cancer Res 76, 5933-5944 (2016). [30] C. H. Schmitz et al. “Design and implementation of dynamic near-infrared optical tomographic imaging instrumentation for simultaneous dual-breast measurements,” Applied Optics 44, 2140-2153, (2005). [31] S. Amalakanti et al. “Pulse Oximetry Overestimates Oxygen Saturation in COPD”, Respiratory Care, 61, 423-427 (2016). [32] J. Steppan et al., “Cerebral and tissue oximetry”, Best Practice Res. Clin. Anaesthes. 28, 429-439 (2014). [33] S. Fantini, “Dynamic model for the tissue concentration and oxygen saturation of hemoglobin in relation to blood volume, flow velocity, and oxygen consumption: Implications for functional neuroimaging and coherent hemodynamics spectroscopy (CHS),” Neuroimage 85, 202-221 (2014). [34] C. H. Schilling and B. O. Palsson, “The underlying pathway structure of biochemical reaction networks,” Proc. Natl. Acad. Sci., 95, 4193-4198 (1998). [35] P. R. Somvanshi and K. V. Venkatesh, “A conceptual review on systems biology in health and diseases: From biological networks to modern therapeutics,” Systems and Synthetic Biology 8, 99-116 (2014). [36] K. B. et al., “Neuronal firing rate homeostasis is inhibited by sleep and promoted by wake”, Cell 165, 180-191 (2016). [37] A. E. Pereda et al., “Gap junction-mediated electrical transmission: Regulatory mechanisms and plasticity,” Biochim. Biophys. Acta 1828, 134-146 (2013). [38] S. S. Segal “Integration and Modulation of Intercellular Signaling Underlying Blood Flow Control”, J. Vasc. Res., 52, 136-157 (2015). [39] G. W. Wylie, et al., “Using co-variations in the Hb signal to detect visual activation: A near infrared spectroscopic imaging study,” NeuroImage, Vol. 47, 473-481 (2009). [40] H. J. Forman, “Redox-signaling: an evolution from free radicals to aging”, Free Radic Biol Med., 97, 398-407 (2016). [41] D. J. Kominsky et al., “Metabolic Shifts in Immunity and Inflammation”, J Immunol. 184, 4062-4068 (2010). [42] D. D. Thomas “Breathing new life into nitric oxide signaling: A brief review of the interplay between oxygen and nitric oxide”, Redox Biol., 5, 225-233 (2015). [43] I. F. Tannock and J. A. Hickman, “Limits to Personalized Cancer Medicine”, N Engl J Med 375, 1289-1294, (2016). [44] (C. M. Delude, “Deep phenotyping: The details of disease”, Nature, 527 S14-S15 (2015). [45] R. L. Barbour et al., “Method for representations of network-dependent features of the hemoglobin signal in living tissues for detection of breast cancer and other applications”, U.S. Pat. No. 10,105,090B2 (2018). [46] G. Oster, “Network Thermodynamics”, Nature 234, 393-399, (1971). [47] G. F. Oster, “Tellegen's Theorem and Thermodynamic Inequalities”, J. Theor. Biol, 32, 219-241 (1971). [48] A. Fornito et al., “Fundamentals of Brain Network Analysis”, Academic Press, (2016). [49], J. Lei, et al., “Assessing the Healing of Venous Leg Ulcers Using a Noncontact Near-Infrared Optical Imaging Approach”, Adv Wound Care, 7, 134-143, (2018). [50], R. Kwasinski et al., “Tissue Oxygenation Changes to Assess Healing in Venous Leg Ulcers Using Near-Infrared Optical Imaging”, Adv Wound Care, 8, 565-597, (2019). [51]. A. de Paula, “Econometrics of Network Models”, in Advances in Economics and Econometrics“, pp 268-323, (2017), Cambridge University Press, DOI: https://doi.org/10.1017/9781108227162.008 [52] S. M. Golas et al., “Gibbs free energy of protein-protein interactions correlates with ATP production in cancer cells”, J. Biol. Phys., 45, 423-430 (2019). [53] E. A. Rietman et al., “Thermodynamic measures of cancer: Gibbs free energy and entropy of protein-protein interactions”, J. Biol Phys., DOI 10.1007/s10867-016-9410-y, (2016) [54] E. A. Rietman, J. G. Scott, J. A. Tuszynski, and G. L. Klement, “Personalized anticancer therapy selection using molecular landscape topology and thermodynamics,” Oncotarget 8, 18735-18745 (2017). [55] Breitkreutz et al., “Molecular signaling network complexity is correlated with cancer patient survivability,” PNAS, 109, 9209-9212, (2012). [56] R. Kazemi, “Entropy of weighted graphs with the degree-based topological indices as weights,” MATCH Commun. Math. Comput. Chem. 76, 69-80 (2016). [56a] F. Rohart, B. Gautier, A. Singh, and K.-A. Lê Cao, “mixOmics: An R package for 'omics feature selection and multiple data integration,” PLoS Computational Biology 13: e1005752 (2017).[56b] Z. Ahmed, “Practicing precision medicine with intelligently integrated clinical and multi-omics data analysis”, Human Genetics, 14:35 (2020).[57] Open Science Framework: “Resting-State Simultaneous Dual-Breast Imaging.” OSF Resting-State Simultaneous Dual-Breast Imaging (https://osf.io/4cr3z/) [58] H. L. Graber, Y. Pei, and R. L. Barbour, “Imaging of spatiotemporal coincident states by DC optical tomography,” IEEE Transactions on Medical Imaging 21, 852-866 (2002). [59] Y. Pei, H. L. Graber, and R. L. Barbour, “Influence of systematic errors in reference states on image quality and on stability of derived information for DC optical imaging,” Applied Optics 40, 5755-5769 (2001). [60] R. L. Barbour and H. L. Graber, “Characterization of hemoglobin dynamics as a co-varying system in the resting state: Evidence of functional bias of preferred states and sensitivity to disease,” Poster #220 at 2016 Biennial Meeting of The Society for Functional Near Infrared Spectroscopy (Paris, Oct. 13-16, 2016)). [61] R. L. Barbour, et al., PLoS One 13, e0198210.https://doi.org/10.1371/journal.pone.0198210, (2018). [62] A.-L. Barabási and R. Albert, “Emergence of scaling in random networks,” Science 286, 509-512 (1999). [63] R. Albert, H. Jeong, and A.-L. Barabási, “Error and attack tolerance of complex networks,” Nature 406, 378-382 (2000). [64] Y. M. Omar and P. Plapper, “A survey of information entropy metrics for complex networks,” Entropy 22, doi:10.3390/e22121417 (2020). [65] R. M. Mehmood and H. J. Lee, “Exploration of prominent frequency wave in EEG signals from brain sensors network,” Int. J. Distributed Sensor Networks 2015, Article ID 386057 (2015). [66] R. B. Buxton, “The physics of functional magnetic resonance imaging (fMRI),” Reports on Progress in Physics 76, 096601 (2013). [67] M. A. Lindquist, J. M. Loh, L. Y. Atlas, and T. D. Wager, “Modeling the hemodynamic response function in fMRI: Efficiency, bias and mis-modeling,” NeuroImage 45, S187-S198 (2009). [68] N. H. Yuen, N. Osachoff, and J. J. Chen, “Intrinsic frequencies of the resting-state fMRI signal: The frequency dependence of functional connectivity and the effect of mode mixing,” Frontiers Neurosci. 13, 900 (2019). [69] M. Gheorghe and V. Mitrana, “A formal language-based approach in biology”, Compoarative and Functional Genomics 5, 91-94 (2004). [70] W. T. Fitch and A. D. Friederici, “Artificial grammar learning meets formal language theory: An overview”, Phil. Trans. R. Soc. B 367, 1933-1955 (2012). [71] K. S. Suresh Kumar, Electrical Circuits and Networks. Pearson Education Canada (2009). ISBN 978-8131713907. [72] TR. Kuphaldt, “DC Network Analysis,” Chapter 10 in Lessons in Electrical Circuits, Volume I—DC, 5.sup.th Ed. Open Book Project (2006). Available online at https://www.allaboutcircuits.com/textbook/direct-current/), [73] C H. Schilling and B. O. Palsson, “The underlying pathway structure of biochemical reaction networks,” Proc. Natl. Acad. Sci. 95, 4193-4198 (1998). [74] S Schuster, T. Dandekar, and D. A. Fell, “Detection of elementary flux modes in biochemical networks: A promising tool for pathway analysis and metabolic engineering,” Trends in Biotechnology 17, 53-60 (1999). [75] L. R. Rabiner, “A tutorial on hidden Markov models and selected applications in speech recognition,” Proceedings of the IEEE 77, 257-286 (1989). [76] S. Umeyama, “An eigendecomposition approach to weighted graph matching problems,” IEEE Transactions on Pattern Analysis and Machine Intelligence 10, 695-703 (1988). [77] C. H. Schilling, D. Letscher, and B. O. Palsson, “Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from a pathway-oriented perspective,” J. Theoretical Biology 203, 229-248 (2000). [78] K. E. Stephan, W. D. Penny, J. Daunizeau, R. J. Moran, and K. J. Friston, “Bayesian model selection for group studies,” NeuroImage 46, 1004-1017 (2009). [79] G. A. Pavlopoulos, M. Secrier, C. N. Moschopoulos, T. G. Soldatos, S. Kossida, J. Aerts, R. Schneider, and P. G. Bagos, “Using graph theory to analyze biological networks,” BioData Mining 4 (2011). [80] A. K. Jain, J. Mao, and K. M. Mohiuddin, “Artificial neural networks: A tutorial,” IEEE Computer Magazine, March 1996, 31-44. [81] L. J. Lancashire, C. Lemetre, and G. R. Bal, “An introduction to artificial neural networks in bioinformatics—application to complex microarray and mass spectrometry datasets in cancer studies,” Briefings in Bioinformatics 10, 315-329 (2009).